Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

70.48 +0.10 (+0.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Top 3 Health Care Stocks That May Explode In Q3
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,200 Today
Via Benzinga
What 22 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
3 Healthcare Stocks to Buy at a 52-Week Low in July
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds. 
Via InvestorPlace
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),... 
Via Benzinga
Market Whales and Their Recent Bets on Edwards Lifesciences Options
Via Benzinga
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
Via Benzinga
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Edwards Lifesciences Stock Tumbles, Highlights Slowdown In TAVR Business
Edwards Lifesciences reported Q2 results, sales increased 7% to $1.632B, TAVR sales grew 5%, company to acquire JenaValve and Endotronix, lowers TAVR guidance. 
Via Benzinga
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Stocks Bouncing Back After Data Hints At 'Soft Landing'
Stocks are on the move midday, as Wall Street weighs an upbeat second-quarter gross domestic product (GDP) reading with the recent tech sector selloff. 
Via Talk Markets
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown. 
Via Benzinga
Topics Economy
Exposures Economy
This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
Viking Therapeutics stock is up on Thursday as VKTX investors react to the company preparing for a Phase 3 trial of its weight loss drug. 
Via InvestorPlace
LINE Stock: 7 Things to Know as Lineage Starts Trading Today
Lineage stock is going to start trading later today and we have all of the details investors need to know about LINE shares on Thursday. 
Via InvestorPlace
Why Is Edwards Lifesciences (EW) Stock Down 22% Today?
Edwards Lifesciences stock is down on Thursday as EW investors digest the company's latest earnings report and outlook this morning. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech... 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year
The company now expects full-year sales in its TAVR division to climb 5% to 7%. 
Via Investor's Business Daily
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.